DR REDDYS LABORATORIES LTD

Dr. Reddy’s Laboratories Limited is an integrated pharmaceutical company that develops, manufactures, and markets a broad portfolio of generic prescription drugs, over-the-counter medicines, biosimilars, and consumer healthcare products. The company operates across three reportable segments: Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Others. Global Generics offers finished dosage forms ready for patient use, while PSAI supplies active pharmaceutical ingredients and provides custom contract research and manufacturing services. Its customer base includes patients, pharmacies, healthcare providers, innovator and biotechnology companies, and commercialization partners.

Headquartered in Hyderabad, Telangana, India, the enterprise conducts business across major international territories, including North America, Europe, India, Russia and other countries of the former Soviet Union, and parts of Latin America, Africa, and Asia. In India alone, the company manages approximately 530 branded products, deploying roughly 10,000 sales representatives and frontline managers who supply about 6,500 wholesalers via clearing and forwarding agents.

Summary of the business section of Dr Reddys Laboratories's latest annual report, written by StockData.